# Furmonertinib for EGFR-mutant advanced non-small cell lung cancer: a glittering diamond in the rough of EGFR-TKI

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/furmonertinib-for-egfr-mutant-advanced-non-small-cell-lung-cancer-a-glittering/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jianghua Ding,Xingjing Ding,Jiao Zeng,Xiaoqun Liu |
| Citations | 17 |
| DOI | 10.3389/fphar.2024.1357913 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1357913/pdf |
| OpenAlex ID | https://openalex.org/W4391948854 |
| PMID | 38440180 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Jianghua Ding](https://scholariq.org/researchers/jianghua-ding/)

## Paper journal

- [Frontiers in Pharmacology](https://scholariq.org/journals/frontiers-in-pharmacology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.